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Abstract
Background: Research has shown that ethnicity is a significant predictor of Hodgkin lymphoma (HL). Variations in
cancer incidence among ethnic groups in the same country can lead to important information in the search for etiological
factors. Other risk factors important in the etiology of HL are medical history and exposure to pesticides. In this report
we investigated the association between ethnicity and HL in the presence of medical history, and exposure to pesticides.
Methods: The data resulting from a matched population-based case-control study conducted in six provinces of Canada
(Ontario, Quebec, Manitoba, Saskatchewan, Alberta, and British Columbia) was analyzed to determine whether or not
there was any association between ethnicity and incidence of HL when adjusted for personal medical history and
pesticide exposure. Information on ethnicity, personal medical history, and pesticide exposure was collected by
questionnaires via mail on 316 men diagnosed with HL; and on 1506 controls. A conditional logistic regression was
utilized and results were presented as odds ratios and 95% confidence intervals.
Results: In our study population, the distribution of ethnic groups was: 38.5% North American, 15% British, 8.4%
Western European, 8.2% Eastern European, 1.7% Asian, 1.4% Scandinavian and 27% of other ethnic origin. Compared to
North Americans (i) the risk of HL was greater among the Eastern European descendents (Odds Ratio (ORadj): 1.82; 95%
confidence interval (CI): 1.02, 3.25) and Western European (ORadj: 1.62; 95% CI: 0.95–2.76) descent population
(borderline significance at 5% level); and (ii) the risk of HL was lower in Asian descents. Diagnosis with measles (ORadj:
0.72, 95% C.I.: 0.53–0.98) and/or positive history of allergy desensitization shots (ORadj: 0.55, 95% C.I.: 0.30–0.99) were
negatively associated with the incidence of HL, while diagnosis with acne (ORadj: 2.12, 95% C.I.: 1.19–3.78), shingles
(ORadj: 2.41, 95% C.I.: 1.38–4.22) and positive family history of cancer (ORadj: 1.93, 95% C.I.: 1.40–2.65) increased the
risk of HL. Exposure to individual herbicide dichlorprop showed an increased risk of HL (ORadj: 6.35, 95% C.I.: 1.56–
25.92).
Conclusion: In Canada, compared to North Americans descendents, the risk of HL was significantly greater among the
Eastern European and Western European descent population. Our results related to association between ethnicity and
HL support the findings reported by other researchers. Our data showed that subjects who were diagnosed with measles
or had allergy desensitization shots negatively associated with the incidence of HL; and other medical conditions, ever
diagnosed with acne, and positive family history of cancer were positively associated with the incidence of HL.
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Backround
Hodgkin lymphoma (HL) is a specialized form of lym-
phoma. HL has characteristics that distinguish it from all
other cancers of the lymphatic system. An abnormal cell
called the Reed-Sternberg cell, a large and malignant cell
is found in the HL tissues [1]. HL is a complex of related
conditions that are, in part mediated by genetic suscepti-
bilities, infectious diseases, and immune deficits [1]. HL
has been increasing in incidence in many countries
around the world, particularly in the West [2]. Incidence
rates have been increasing in adolescents and young
adults more than in any other age group. Recently it is
reported that all HL subtypes pooled, has a bimodal peak
at ages 15–34 years and over 60 years in most European,
American, Hispanic and Australian populations, and Jews
born in Israel with incidence rates of around 6 per 100
000 per year in the over-60-year-olds. However, cases with
Asian origin show few cases at all in the younger ages;
rates increase with age but the highest rates are only half
that of the European disease [1]. The finding of associa-
tion between ethnicity and increased risk of HL has been
reported by other researchers as well [3,4]. Ethnicity in
health research helps us to understand causes of disease
and, particularly the relative contributions of genetic and
environmental factors [5-10]. Variations in cancer inci-
dence and ethnic groups in the same country can lead to
some important information about the search of etiologi-
cal factors. The distribution of ethnic groups varies signif-
icantly among different regions of Canada.
A study conducted in the United States compared the
occurrence of HL, in Chinese, Japanese, Filipino and
Asian Indian populations living in the United States to the
occurrence in similar groups living in Asia and observed
that incidence rates were quite low in all Asian subgroups,
but approximately double in United States Asians com-
pared to in native Asians [11]. Stiller et al. [12] suggest
that the occurrence of HL in early childhood is related
more to ethnicity than to geographical location and may
reflect genetic factors or environmental exposures specific
to the lifestyle of particular ethnic groups.
Recently, McDuffie et al. [13] and Hoppe et al [14]
reported that there are several putative risk factors for HL,
which include occupational exposure to certain chemicals
and specific pesticides, personal history of certain cancers
and other medical conditions, such as infectious disease
(bacterial and viral), immune related disorders including
autoimmune (e.g. rheumatoid arthritis) and chronic
inflammatory diseases (e.g. inflammatory bowel disease),
and tonsillectomy. Some antecedent selected medical
conditions have been positively associated with HL and
other cancers [15-18], while there are some inconsistent
findings. Several studies have shown an inverse relation-
ship between prior allergies and cancer [19-23].
Zahm et al [24] reported that there is some genetic resist-
ance to HL in Asians but environmental factors, such as
agricultural exposures have some influence as well. Expo-
sure to pesticides has been associated with an increased
incidence of Hodgkin lymphoma in many studies, but not
in all. A Swedish study found a non significant increased
risk of HL in those who have been exposed to phenoxy
acid herbicides [25,26]. Another Swedish study showed
that exposure to phenoxy acid herbicides has been associ-
ated with increased risk of HL [27]. Hardel et al. [28]
reported that combined exposure to phenoxy acids and
chlorophenols increase the risk of HL. A study in Kansas
[24] found no association among men between HL and
use of insecticides on crops or on animals. Swedish study
of pesticides applicators did not found any increased risk
of HL [29]. Another cohort study conducted among work-
ers at a phenoxyherbicide-manufacturing plant in Ger-
many did not find significantly high risk of HL [30].
In this report, we investigated the association between
ethnicity and incidence of HL in the presence of medical
history, and exposure to pesticides.
Methods
Details of the study design and methodology have been
previously published [31,32]. Briefly, we conducted a
matched population based case-control study of men res-
ident in six Canadian provinces (Quebec, Ontario, Mani-
toba, Saskatchewan, Alberta, and British Columbia) to
test the pesticide-exposure hypothesis related to four rare
tumors (Hodgkin's Lymphoma (HL), Non-Hodgkin's
Lymphoma (NHL), Multiple Myeloma (MM), and Soft-
Tissue sarcoma (STS)). There were total 1528 cases diag-
nosed with four types of tumours under investigation (HL
= 316, MM = 342, NHL = 513, and STS = 357, Total
number of cases = 1528). Each case was supposed to have
one matched control (match on ± 2 years and province of
residence), however some problems were faced in recruit-
ing controls in older age groups, specially 69 years and
older, therefore we have 1506 controls. To analyze data
for each specific tumour type, all controls from the entire
case groups were used. For example in this report statisti-
cal analysis is based on 316 (68.4% of those contacted)
HL cases and all 1506 (48.0% of those contacted) con-
trols. The most common reasons for not participating
were death, change of address and refusal for both study
groups. The study had approximately five matched con-
trols for each HL case.
This report is based solely on cases diagnosed with HL and
to test the secondary hypothesis mentioned above. Inci-
dent cases among men, ages 19 years or over, with first
diagnosis of HL (ICD-9 201) between September 1, 1991
to December 31, 1994 were eligible. Cases were ascer-
tained from provincial Cancer Registries except in Que-BMC Cancer 2009, 9:141 http://www.biomedcentral.com/1471-2407/9/141
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bec. For Quebec, hospital ascertainment was used. After
physician consent was received, postal questionnaires and
informed consent forms were mailed to potential cases.
Control subjects were matched by age ± 2 years to be com-
parable with the age distribution of the entire case group
[HL, NHL, MM, and STS] within each province of resi-
dence. Potential controls (men, 19 ages and older)
selected at random within age constraints from the pro-
vincial Health Insurance records (Alberta, Saskatchewan,
Manitoba, Quebec), computerized telephone listings
(Ontario), or voters' lists (British Columbia). Postal ques-
tionnaires and informed consent forms were mailed to
potential controls, and information collected from all of
the participating control subjects was used in the statisti-
cal analyses of each cancer site. Deceased subjects were
ineligible as either cases or controls.
The study design consisted of two stages: Stage 1 was a
self-administered postal questionnaire; and Stage 2 was
detailed pesticide exposure information collected via tele-
phone interview. With permission, we modified a pesti-
cide exposure questionnaire developed by Hoar et al. [33]
to create these questionnaires.
The postal questionnaires captured demographic details,
personal medical history, cigarette smoking history, life-
time occupational history and specific occupational expo-
sures of interest. Each subject who reported 10 hours per
year or more of exposure to pesticides (in any combina-
tion of compounds) as defined by the screening ques-
tions, and a 15% random sample of the remainder was
mailed a list of pesticides (both chemical and brand
names) and an information letter. Each subject was subse-
quently telephoned to obtain details of pesticide use.
Exposure to individual herbicide, insecticides, fumigant,
and fungicide was coded as 'Yes' if the response to follow-
ing question 'Did you use it at work, in your home garden
or as a hobby' was either work or home or hobby other-
wise it was coded as 'No'. All individuals who had expo-
sure less than 10 hours based on the postal questionnaire
and were not a part of 15% random sample were consid-
ered as 'No exposure to individuals chemical listed in the
telephone questionnaire.'
The telephone questionnaire characterized exposure to
individual pesticides. The pesticide data were collected at
several levels beginning with the broadest categories (e.g.
minimal exposure, occupations with potential pesticide
exposure) and progressing sequentially from major
classes (e.g., herbicides); to chemical groups (e.g., phe-
noxy herbicides); and finally to individual components
(e.g., 2,4-D, MCPA, and 2,4,5-T). The listed pesticides
(Additional file 1: Table S1) were chosen for inclusion for
the following reasons: (a) if the compound was ever regis-
tered for use in Canada and reviewed by the IARC; (b) if
the pesticide was recently banned or restricted in Canada
by the federal licensing agency; or (c) if the pesticide was
commonly used in Canada for specific purposes [34-37].
Ethical Approval
The letters of informed consent, the questionnaires and
other written material provided to potential subjects were
submitted to and approved by each of the relevant agen-
cies in each province. For Saskatchewan, the University of
Saskatchewan Biomedical Research Ethics Board (#89-
12); for British Columbia, the University of British
Columbia Behavioural Research Ethics Board (#B91-
185); for Quebec, the University of McGill Human Ethics
Board; for Alberta, the University of Alberta Health
Research Ethics Board (Biomedical Panel); for Manitoba,
the University of Manitoba Biomedical Research Ethics
Board; and for Ontario, the University of Toronto Health
Sciences Research Board approved the study protocol. All
information that could be used to identify the individuals
remained within the province of origin under the control
of each province's principal investigator. After receiving
permission to contact a potential case by the attending
physician, a letter of informed consent and a question-
naire was mailed. Relatives of cases known to be deceased
at ascertainment were not contacted because of the need
to obtain detailed information concerning occupation
and occupational exposures including a variety of types of
pesticides. Control subjects were contacted directly by
mail. Living control subjects were eligible.
Definitions
Several definitions used in this manuscript are given
below.
Ethnicity
In the questionnaire, each individual was asked for birth-
place (the country or part of the world) of each of his four
grandparents. Since there have been reports that studies of
pesticide exposure conducted among certain ethnic
groups have produced higher odds ratios than similar
types and doses of exposure among other ethnic groups,
this question was included in our study. According to the
information based on the ethnicity of the father's father,
father's mother, mother's father, and mother's mother,
the respondents' ethnicity was defined. Horne et al. [38],
classified each individual predominantly in a particular
ethnicity if he were 4/4 (all four grandparents) or 3/4
(three grandparents out of four) from that group. Any
individual who had less than 3 grandparents from the
same ethnic group was classified in the "other" category.
According to that definition we formed seven ethnic cate-
gories. The composition of the categories is based on
geography and some of the groups are quite broad due to
aggregate grouping with small numbers. The ethnic cate-
gories are as follows: Scandinavian (Denmark, Finland,BMC Cancer 2009, 9:141 http://www.biomedcentral.com/1471-2407/9/141
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Norway and Sweden), Eastern European (Austria, Bul-
garia, Czechoslovakia, Hungary, Poland, Romania, Ser-
bia, Yugoslavia, Russia and Ukraine), Western European
(Belgium, France, Greece, Germany, Holland, Italy, Lux-
embourg, Portugal, Spain and Switzerland), North Amer-
ican (Canada and United States), Asian (Asia, China,
India, Japan, Korea, Laos, Pakistan, Philippines and Viet-
nam), British (Australia, England, Great Britain, Ireland,
New Zealand, Scotland and Wales), and other (Adopted,
Africa, American Indian, Central American, Europe, Ice-
land, Malta, Mexico, Mediterranean Sea, Middle East,
Pacific Islands, Puerto Rico, South America, and West
Indies).
Pesticide
Pesticide is a generic term which refers to a host of com-
pounds of diverse chemical structure and biological
modes of action. In this study, the term pesticide refers
primarily to herbicides, insecticides, fumigants and fungi-
cides.
Pesticide Exposure
We conducted a pilot study [39] in each provincial region
to test questionnaires and to determine a working defini-
tion of pesticide exposure to distinguish between environ-
mental (which includes bystander and incidental) and
more intensive exposure. Non-occupational use of pesti-
cides (home, garden, and hobby) was included. Based on
the statistical analysis of pilot study data, it was decided
that the most efficient definition of pesticide exposure,
which discriminated (a) between incidental, bystander,
and environmental exposure as compared with more
intensive exposure and (b) between cases and controls,
was a cumulative exposure = 10 hrs/year to any combina-
tion of pesticides. The screening questions in the postal
questionnaire were used to prompt telephone interviews
among those with cumulative exposure of = 10 hrs/year to
any combination of herbicides, insecticides, fungicides,
fumigants, and/or algicides.
Medical History
Information on antecedent medical history, and family
history of cancer was collected (see Table 1). Information
was collected on infectious disease (bacterial and viral),
allergies, acne, and immune disorders which includes
autoimmune and inflammatory disorders, and asthma.
Family history of cancer
Family is restricted to first degree relatives (parents, sib-
lings, and offspring) who share, on average, one half of
the respondents' genes. Family excludes half-siblings,
adopted siblings and children, step-children and all other
non-related individuals. Family excludes the index sub-
jects.
Statistical Analyses
Data were entered into a custom designed SPSS-data entry
program. Results were presented as frequencies for cate-
Table 1: Personal Medical History of HL Cases and Controls
HL (n = 316) Controls (n = 1506) ORa (95% Cl)
n% n %
Asthma 22 7.0 107 7.1 0.90 (0.53, 1.54)
Acne 30 9.5 48 3.2 2.05 (1.21, 3.48)
Chicken pox 155 49.0 638 42.4 0.94 (0.71, 1.25)
Diabetes 12 3.8 99 6.6 1.08 (0.55, 2.09)
Hay fever 28 8.9 155 10.3 0.68 (0.43, 1.07)
Measles 153 48.4 888 59.0 0.76 (0.57,0.99)
Mumps 137 43.3 661 43.9 1.11 (0.85,1.47)
Mononucleuosis 23 7.3 48 3.2 1.30 (0.74, 2.72)
Rheumatoid arthritis 8 2.53 88 5.84 0.78 (0.36, 1.69)
Rheumatic fever 4 1.3 36 2.4 0.87 (0.29, 2.58)
Shingles 28 8.9 87 5.8 2.16 (1.31,3.56)
Ringworm 14 4.4 89 5.9 0.74 (0.40, 1.37)
Urinary tract infection 24 7.6 155 10.3 1.06 (0.66,1.72)
Whooping cough 30 9.5 220 14.6 0.90 (0.57, 1.40)
Allergies 77 24.4 378 25.1 0.81 (0.60, 1.11)
Allergy desensitization shots 19 6.6 114 8.1 0.66 (0.38, 1.14)
Patch skin test for allergy 14 5.0 60 4.3 1.14 (0.59, 2.20)
Treatment for head or body lice or scabies 21 7.3 124 8.7 0.68 (0.41, 1.15)
Tonsillectomy 76 26.5 429 30.1 1.02 (0.74, 1.41)
First degree relative with cancer 104 34.0 498 33.8 1.79 (1.33, 2.42)
ORa calculated with strata for the variables of age (5 year groups) and province of residence.
Statistically significant results are bold.BMC Cancer 2009, 9:141 http://www.biomedcentral.com/1471-2407/9/141
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gorical variables and mean, standard deviation (SD) or
standard error (SE) for continuous variables for cases and
controls separately. A bivariate analysis was conducted to
determine the association between each explanatory vari-
able and HL outcome. Based on this model building pro-
cedure explanatory variables with p < 0.20 were selected
for the multivariate model. Statistically significant (p <
0.05) variables and important explanatory variables were
considered for the final multivariate model adjusting for
age and province of residence. Frequency matching by
five-year intervals and geographical region was used in
order to conduct conditional logistic regression (using
strata defined on 'cross-classifying 5-years intervals and
province of residence') to compute adjusted odds ratios
(ORadj) and 95% confidence intervals (95% CI).
Results
The cases were significantly younger (mean age ± standard
deviation (SD): 40.2 ± 15.9) compared to controls (54.1
± 16.4). 44.6% HL cases were younger than 35 years;
31.6% cases were in the age group = 35 and <50, and
23.4% were 50 years and older. There were no significant
difference between HL cases and controls by region (Addi-
tional file 2: Table S2). The distribution of ethnic groups
varied significantly among different regions of Canada
(Additional file 3: Table S3). Based on the population
case-control study conducted during 1991–1994, there
were 15% of Eastern European descent in the Prairies
(Alberta, Saskatchewan, and Manitoba); 12% Western
European descent in Ontario; 83% North American
descent in Quebec; 3% Asian descent in Ontario and Brit-
ish Columbia and 30% British descent in British Colum-
bia. Overall, 28% of cases and 27% of controls were
categorized into "Other" category. The distribution of eth-
nicities within the "Other" category is reported in a sepa-
rate table, which is presented in the Additional file 4:
Table S4.
Personal medical history of cases and population-based
controls are summarized and compared in Table 1. Most
of the personal medical history variables were not found
to be associated with risk of HL. Those diagnosed with
acne (ORadj = 2.05, 95% CI = 1.21 – 3.48) and with shin-
gles (ORadj = 2.16, 95% CI = 1.31 – 3.56) were positively
associated with risk of HL. Those diagnosed with measles
were negatively associated with risk of HL (ORadj = 0.76,
95% CI = 0.57 – 0.99). A statistically significant (ORadj =
1.79, 95% CI = 1.33 – 2.42) increased risk for HL was
found to be associated with a history of first-degree rela-
tives with cancer. In addition to that herbicide Dichlor-
prop (ORadj = 3.85, 95% CI = 1.19 – 12.47) was
positively associated with increasing the risk of HL (Table
2). Based on conditional logistic multivariable regression
modeling, the following factors independently increased
the risk of HL: Eastern European descent, exposure to
Dichlorprop, immediate family history of cancer, per-
sonal medical history of acne and shingles. Those diag-
nosed with measles or treated with allergy desensitization
shots were negatively associated with HL (Table 3). The
risk of HL was significantly greater among the Eastern
European (ORadj = 1.82, 95% CI = 1.02 – 3.25) and West-
ern European (ORadj = 1.62, 95% CI = 0.95 – 2.76)
descent populations in Canada.
Discussion
The concept of ethnicity, ancestry, and race are widely
used in molecular epidemiologic research, and are often
based on the assumption that these correlate with
Table 2: Results based on univariate conditional logistic regression models.
Variable Sample size ORa (95% CI)
Ethnicity (reference is North American)
Scandinavian 1822 (1506 Controls; 316 Cases) 0.34 (0.04, 2.80)
Eastern European 1822 (1506 Controls; 316 Cases) 1.42 (0.83, 2.44)
Western European 1822 (1506 Controls; 316 Cases) 1.42 (0.90, 2.40)
Asian 1822 (1506 Controls; 316 Cases) 0.14 (0.02, 1.07)
British 1822 (1506 Controls; 316 Cases) 1.04 (0.66, 1.65)
Other 1822 (1506 Controls; 316 Cases) 0.94 (0.67, 1.33)
Herbicides
Dichlorprop 1822 (1506 Controls; 316 Cases) 3.85 (1.19–12.47)
Personal Medical History
Diagnosed with measles 1822 (1506 Controls; 316 Cases) 0.76 (0.57, 1.00)
Ever diagnosed with acne 1822 (1506 Controls; 316 Cases) 2.05 (1.21, 3.48)
Diagnosed with shingles 1822 (1506 Controls; 316 Cases) 2.16 (1.31, 3.56)
First degree relative with cancer 1776 (1471 Controls; 306 Cases) 1.79 (1.33,2.42)
Allergy desensitization shots 1705 (1417 Controls; 288 Cases) 0.66 (0.38, 1.14)
Results reported for variables with p < 0.20
ORa calculated with strata for the variables of age (5 year groups) and province of residence.
Statistically significant (p < 0.05) results are bold.BMC Cancer 2009, 9:141 http://www.biomedcentral.com/1471-2407/9/141
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increased genetic homogeneity among people claiming a
similar identity. The important finding of this report is
that compared to North Americans: (i) Eastern Europeans
(p = 0.05) and Western European (p = 0.09) were signifi-
cantly at higher risk of developing HL, and that (ii) Asians
were significantly (p = 0.09) at lower risk of developing
HL. Findings from descriptive and multivariate logistic
regression analyses of our study suggest incidence of HL
was significantly higher [OR, 95% C.I.: 1.82 (1.02, 3.25)]
compared to subject of North Americans descent. Inci-
dence of HL was significantly (borderline) higher in West-
ern European compared to North Americans; (ii)
exposure to herbicide dichlorprop is significantly associ-
ated with the increased risk of HL; (iii) personal medical
history variables: diagnosed with measles and ever had
allergy desensitization shots were significantly associated
with decreased incidence of HL. In contrast, some of the
other personal medical history variables: 'Ever diagnosed
with acne', 'Diagnosed with shingles', and 'First degree rel-
atives diagnosed with cancer' were significantly associated
with increased incidence of HL. Our results support find-
ings of high incidence of lymphomas and other cancers in
European descent populations. For example, Leukemia
rates are higher in Americans of European descent than
among those of any other race/ethnicity [40], and as
reported by Spallek et al [41] that for acute non-lym-
phocytic leukemia, Hodgkin's disease 1.34 (1.13–1.59)
and Non-Hodgkin/Burkitt lymphoma, the proportions
are slightly increased for Turkish children (A study based
at the German Childhood Cancer Registry). Our findings
also suggest that that there is some genetic resistance to
HL in Asians but also show that environmental factors
have some influence, which are consistent with the find-
ings reported by Zahm et al [24]. Genetic resistance to HL
in Asian population is also supported by another study,
which uniformly collected population-based data from
the US and Asia, and authors reported that given environ-
mental and lifestyle differences between the US and Asia,
the consistently low rates of HL in Asians suggest genetic
resistance to disease development [11].
As reported by other authors, the incidence of HL varies in
different ethnic groups [10]; and incidence rates increased
with advancing age at diagnosis and that white adoles-
cents 15–19 years old exhibit the highest rates [42]. In
another study Cozen et al. reported that blacks experience
a slightly higher incidence of HL than whites in childhood
but a lower incidence in young adulthood [43]. Ethnicity
can serve as surrogate measures to identify high-risk
groups. Groups that have a particularly high incidence or
strong familial aggregation of disease may represent an
optimal resource in which to identify or characterize dis-
ease genes. Another article based on Canadian Case-con-
trol population study showed that there is a familial
aggregation among HL cases (manuscript accepted for
publication in BMC Cancer).
It has been reported that HL may be a rare consequence of
a common infection, with the probability of oncogenesis
increasing with age at the time of infection. Patients with
a history of infectious mononucleosis, a disease associ-
ated with late exposure to EBV, have a threefold increase
in the risk of HL [44]. We did not collect information on
EBV; however, a descriptive cross tabs analysis showed a
significant association between diagnosis of mononucleo-
sis and incidence of HL (7.3% HL cases were diagnosed
with mononucleosis compared to 3.2% controls diag-
nosed with mononucleosis). No significant (p = 0.36)
association was observed when a conditional logistic
regression stratified by province and age was conducted,
and diagnosis of mononucleosis did not enter into the
multivariable conditional logistic regression. As reported
by Hardell and Bengtsson [45], one aspect in the aetiology
of HL is a possible interaction between chemical expo-
sure, and viral infections such as EBV. Because of lack of
information on EBV, we investigated the interaction
between mononucleosis and pesticide exposure, which
was not significant. Diagnosis of allergies were inversely
associated with HL at p < 0.2 (Table 2), which is consistent
with findings of earlier studies [20-23]. Our data showed
that previous history of desensitization (those who were
diagnosed with allergies, 27.2% has desensitization
shots) was negatively associate with risk of HL. Diagnosis
of shingles was positively associated with increased risk of
HL, which could be due to weak immune system as a con-
sequence of diagnosis of shingles. Most of the studies in
the literature have reported that diagnosis of shingles is
usually a consequence of HL, however in our case-control
Table 3: Results based on multivariable conditional logistic 
regression
Variable ORa (95% CI)
Ethnicity (reference is North American)
Scandinavian 0.46 (0.05,3.71)
Eastern European 1.82 (1.02,3.25)
Western European 1.62 (0.95,2.76)
Asian 0.17 (0.02,1.33)
British 1.00 (0.60,1.67)
Other 1.03 (0.70,1.50)
Herbicides
Dichlorprop 6.35 (1.56,25.92)
Personal Medical History
Diagnosed with measles 0.72 (0.53,0.98)
Ever diagnosed with acne 2.12 (1.19,3.78)
Diagnosed with shingles 2.41 (1.38,4.22)
First degree relative with cancer 1.93 (1.40,2.65)
Allergy desensitization shots 0.55 (0.30,0.99)
ORa calculated with strata for the variables of age (5 year groups) and 
province of residence.
Statistically significant (p < 0.05) results are bold.BMC Cancer 2009, 9:141 http://www.biomedcentral.com/1471-2407/9/141
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study information on previous medical conditions
(including diagnosis of shingles) was collected.
Not only heredity and genetic factors but also environ-
mental or non-genetic factors may increase the risk of
Hodgkin lymphoma. Association between exposure to
pesticides and increased risk of HL is controversial. Some
studies have reported no association between exposure to
(i) phenoxy acid herbicides and increased risk of HL
[24,26,31], (ii) insecticides and increased risk of HL [31],
while other studies have reported an association between
exposure to phenoxy herbicides and HL [27,28]. Our
study showed a positive significant association between
exposure to Dichlorprop and HL, when ethnicity and
some of the selected medical history variables were
already in the model.
Like any other epidemiological case-control study, our
study had strengths and limitations. Some of the strengths
of our study are the following: it included a large number
of cases and controls with approximately 5 controls per
case; we conducted a pilot study to determine a suitable
definition of pesticide exposure and we tested the study
procedures prior to implementation; a reference patholo-
gist reviewed the slides and confirmed that the diagnosis
of 316 HL cases and slides were unavailable for the
remainder; pesticide exposure was defined by 10 hours or
more exposure per year to delineate between environmen-
tal and more intense exposure to pesticides, and, finally,
the study includes men who are exposed to pesticides
both indoors such as in animal confinement buildings
and grain elevators and manufacturing and also outdoors
such as in grain farming and commercial applications.
The main limitation of our study was the lack of informa-
tion on Epstein-Barr virus (EBV). HL has been suspected
to have an infectious precursor. Recent molecular studies
have identified EBV latent infection in up to 50% of HL
tumours [46]. One other limitation of our study was the
lack of information on income, so we were unable to
explore the relationship between HL and socioeconomic
status.
Conclusion
In Canada, compared to North Americans descendents,
the risk of HL was significantly greater among the Eastern
European and Western European descent population. Our
results related to association between ethnicity and HL
support the findings reported by other researchers. Our
data showed that subjects who were diagnosed with mea-
sles or had allergy desensitization shots negatively associ-
ated with the incidence of HL; and other medical
conditions, ever diagnosed with acne, and positive family
history of cancer were positively associated with the inci-
dence of HL.
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